Raz Sivan, Koren Ariel, Dan Orrie, Levin Carina
Department of Behavioral Sciences, The Center for Psychobiological Research, The Max Stern Yezreel Valley College, Israel.
Department of Psychology, Tel Hai College, Israel.
Ann N Y Acad Sci. 2016 Jul;1375(1):19-27. doi: 10.1111/nyas.13103.
While β-thalassemia major (β-TM)-related physiological complications have been well established, less is known about implications for neuropsychological and cognitive function. The few existing studies have focused almost exclusively on children. We evaluated cognitive function in adult β-TM patients compared to healthy controls (study 1) and in β-TM patients before and after blood transfusion (study 2). Performance intelligence quotient (IQ) was evaluated with four subtests from the Wechsler Adult Intelligence Scale (WAIS-III). Attention functions were evaluated using the online continuous performance test (OCPT). The results of study 1 revealed poorer performance of β-TM patients on three of the four intelligence subtests, with significantly lower total performance IQ scores compared with controls. The percentage of participants with abnormal performance IQ (<85) was almost five times higher in the β-TM group (58%) than in the control group (12%). In study 2, significant differences were found in OCPT performance as a function of blood transfusion. Before transfusion, patients had higher rates of omission and commission errors, slower response times (RTs), and lower RT consistency than after transfusion. As β-TM patients' life expectancy is increasing, assessment and treatment of neurocognitive functions should become an integral part of appropriate follow-up to improve patients' quality of life.
虽然重型β地中海贫血(β-TM)相关的生理并发症已得到充分证实,但对于其对神经心理和认知功能的影响却知之甚少。现有的少数研究几乎都集中在儿童身上。我们评估了成年β-TM患者与健康对照者相比的认知功能(研究1)以及β-TM患者输血前后的认知功能(研究2)。使用韦氏成人智力量表(WAIS-III)的四个分测验评估操作智商(IQ)。使用在线持续操作测验(OCPT)评估注意力功能。研究1的结果显示,β-TM患者在四个智力分测验中的三个上表现较差,与对照组相比,总操作智商得分显著更低。操作智商异常(<85)的参与者在β-TM组中的比例(58%)几乎是对照组(12%)的五倍。在研究2中,发现OCPT表现因输血情况存在显著差异。输血前,患者的遗漏和错误率更高,反应时间(RT)更慢,且RT一致性低于输血后。由于β-TM患者的预期寿命在增加,神经认知功能的评估和治疗应成为适当随访的一个组成部分,以提高患者的生活质量。